Immunthrombozytopenische Purpura bei Kindern

Adams DM, Kinney TR, O’Branski-Rupp E et al. (1996) High-dose oral dexamethasone therapy for chronic childhood idiopathic thrombocytopenic purpura. J Pediatr 128:281–283 Albayrak D, Islek I, Kalayci AG et al. (1994) Acute immune thrombocytopenic purpura: a comparative study of very high oral doses of methylprednisolone and intravenously administered immune globulin. J Pediatr 125:1004–1007 Amendola G, Cirillo G, Spiezie M et al. (1995) Treatment of childhood chronic idiopathic thrombocytopenic purpura with ascorbate. Clin Pediatr 34:268–270 Ancona KG, Parker RI, Atlas MP et al. (2002) Randomized trial of high-dose methylprednisolone versus intravenous immunoglobulin for the treatment of acute idiopathic thrombocytopenic purpura in children. J Pediatr Hematol Oncol 24:540–544 Andersen JC (1994) Response of resistant idiopathic thrombocytopenic purpura to pulsed high-dose dexamethasone therapy. New Engl J Med 330:1560–1564 Andrew M, Blanchette V, Adams M et al. (1992) A multicenter study of the treatment of childhood chronic idiopathic thrombocytopenic purpura with anti-D. J Pediatr 120:522–527 Barr RD (1995) Response to „treatment of childhood chronic ITP“. Am J Hematol 48:210 Becker T, Küenzlen E, Salama A et al. (1986) Treatment of childhood idiopathic thrombocytopenic purpura with Rhesus antibodies (anti-D). Eur J Pediatr 145:166–169 Benesch M, Kerbl R, Lackner H et al. (2003) Low-dose versus high-dose immunoglobulin for primary treatment of acute immune thrombocytopenic purpura in children: results of a prospective, randomized single-center trial. J Pediatr Hematol Oncol 25:797–800 Bengtson KL, Skinner MA, Ware RE (2003) Successful use of anti-DC20 (Rituximab) in severe, life-threatening childhood immune thrombocytopenic purpura. J Pediatr 143:670–673 Bergsträßer E, Nissen B, Sauter S et al. (1997) Behandlung der akuten Immunthrombozytopenie des Kindesalters mit einer Einzeldosis Immunglobulin. Monatsschr Kinderheilkd 145:526–528 Blanchette V, Carcao M (2000) Approach to the investigation and management of immune thrombocytopenic purpura in children. Semin Hematol 37:299–314 Blanchette VS, Carcao M (2003) Childhood acute immune thrombocytopenic purpura: 20 years later. Semin Thromb Hemost 29:605–617 Blanchette VS, Price V (2003) Childhood chronic immune thrombocytopenic purpura: unresolved issues. J Pediatr Hematol Oncol 25:28–33 Blanchette V, Luke B, Andrew M et al. (1993) A prospective, randomized trial of high dose intravenous immune globulin G therapy, oral prednisone therapy, an no therapy in childhood acute immune thrombocytopenic purpura. J Pediatr 123:989–995 Blanchette V, Imbach P, Andrew M et al. (1994) Randomised trial of intravenous immunglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura. Lancet 344:703–707 Blanchette V, Freedman J, Garvey B (1998) Management of chronic immune thrombocytopenic purpura in children and adults. Semin Hematol 35:36–51 Bolton-Maggs PH (2000) Idiopathic thrombocytopenic purpura. Arch Dis Child 83:220–222 Bolton-Maggs PH, Moon I (1997) Assessment of UK practice for management of acute childhood idiopathic thrombocytopenic purpura against published guidelines. Lancet 350:620–623 Borgna-Pignatti C, Rugolotto S, Nobili B et al. (1997) A trial of high-dose dexamethasone therapy for chronic idiopathic thrombocytopenic purpura in childhood. J Pediatr 130:13–16 Buchanan GR, Holtkamp CA (1984) Prednisone therapy for children with newly diagnosed idiopathic thrombocytopenic purpura. Am J Pediatr Hematol Oncol 6:355–361 Bussel JB (2000) Overview of idiopathic thrombocytopenic purpura: new approach to refractory patients. Semin Oncol 27:91–98 Bussel JB (2000) Splenectomy-sparing strategies for the treatment and long-term maintenance of chronic idiopathic (immune) thrombocytopenic purpura. Semin Hematol 37:1–4 Bussel JB, Novoa M, Shine E et al. (1997) In patients with ITP, does 75 μg/kg of IV anti-D increase the platelet count faster than 50 μg/kg? Blood 90:82b Butros LJ, Bussel JB (2003) Intracranial hemorrhage in immune thrombocytopenic purpura: a retrospective analysis. J Pediatr Hematol Oncol 25:660–664 Calpin C, Dick P, Poon A et al. (1998) Is bone marrow aspiration needed in acute childhood idiopathic thrombocytopenic purpura to rule out leukemia? Arch Pediatr Adolesc Med 152:345–347 Carcao MD, Zipursky A, Butchart S et al. (1998) Short-course oral prednisone therapy in children presenting with acute immune thrombocytopenic purpura (ITP). Acta Paediatr 424:71–74 Chen JS, Wu JM, Chen YJ et al. (1997) Pulsed high-dose dexamethasone therapy in children with chronic idiopathic thrombocytopenic purpura. J Pediatr Hematol Oncol 19:526–529 Choudhry VP, Kashyap R, Ahlawat S et al. (1995) Vinblastine and danazol therapy in steroid resistant childhood chronic idiopathic thrombocytopenic purpura. Int J Hematol 61:157–162 Choulot JJ, Dos Santos A, Prevost J et al. (1998) Idiopathic thrombocytopenic purpura: long-term outcome. Arch Pediatr 5:19–23 De Mattia D, Del Principe D, Del Vecchio GC et al. (2000) Acute childhood idiopathic thrombocytopenic purpura: AIEOP consensus guidelines for diagnosis and treatment. Associazione Italiana di Ematologia e Oncologia Pediatrica. Haematologica 85:420–424 Delgado M, Riela A, Mills J et al. (1994) Thrombocytopenia secondary to high valproate levels in children with epilepsy. J Child Neurol 9:311–314 Di Paola JA, Buchanan GR (2002) Immune thrombocytopenic purpura. Pediatr Clin N Am 49:911–928 Dickerhoff R, Ruecker A von (2000) The clinical course of immune thrombocytopenic purpura in children who did not receive intravenous immunoglobulins or sustained prednisone treatment. J Pediatr 137:629–632 Donato H, Kohan R, Picón A et al. (2001) α-Interferon therapy induces improvement of platelet counts in children with chronic idiopathic thrombocytopenic purpura. J Pediatr Hematol Oncol 23:598–603 Donner M, Holmberg L, Nilsson IM (1987) Type IIB von Willebrand’s disease with probable autosomal recessive inheritance and presenting as thrombocytopenia in infancy. Br J Haematol 66:349–354 Eden OB, Lilleyman JS (1992) Guidelines for management of idiopathic thrombocytopenic purpura. The British Paediatric Haematology Group. Arch Dis Child 67:1056–1058 Fasano MB (1995) Risks and benefits of intravenous immunoglobulin treatment in children. Curr Opin Pediatr 7:688–694 Freiberg A, Mauger D (1998) Efficacy, safety, and dose response of intravenous anti-D immune globulin (WinRho SDF) for the treatment of idiopathic thrombocytopenic purpura in children. Semin Hematol 35:23–27 Fujisawa K, Iyori H, Ohkawa H et al. (2000) A prospective, randomized trial of conventional, dose-accelerated corticosteroids and intravenous immunglobulin in children with newly diagnosed idiopathic thrombocytopenic purpura. Japanese Study Group on Childhood ITP. Int J Hematol 72:376–383 Gaines AR (2000) Acute onset hemoglobinemia and/or hemoglobinuria and sequel following Rh(o)(D) immune globulin intranvenous administration in immune thrombocytopenic purpura patients. Blood 95:2523–2529 George JN (2000) Initial management of immune thrombocytopenic purpura in children: is supportive counseling without therapeutic intervention sufficient? J Pediatr 137:598–599 George J, Woolf S, Raskob G et al. (1996) Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for The American Society of Hematology. Blood 88:3–40 Gereige RS, Barrios NJ (2000) Treatment of childhood acute immune thrombocytopenic purpura with high-dose methylprednisolone, intravenous immunoglobulin, or the combination of both. Health Sci J 19:15–18 Hedlund-Treutinger I, Henter J-I, Elinder G (2003) Randomized study of IVIg and high-dose dexamethasone therapy for children with chronic idiopathic thrombocytopenic purpura. J Pediatr Hematol Oncol 25:139–144 Hedman A, Henter JI, Hedlund I et al. (1997) Prevalence and treatment of chronic idiopathic thrombocytopenic purpura of childhood in Sweden. Acta Paediatr 86:226–227 Heegaard ED, Rosthoj S, Petersen BL et al. (1999) Role of parvovirus B19 infection in childhood idiopathic thrombocytopenic purpura. Acta Paediatr 88:614–617 Hemmila MR, Foley DS, Castle VP et al. (2000) The response to splenectomy in pediatric patients with idiopathic thrombocytopenic purpura who fail high-dose intravenous immune globulin. J Pediatr Surg 35:967–971 Hsiao CC (2000) Epstein-Barr virus associated with immune thrombocytopeni purpura in childhood: a retrospective study. J Paediatr Child Health 36:445–448 Imbach P, Kühne T (1998) Immune thrombocytopenic purpura ITP. Vox Sang 74:309–314 Imbach P, Wagner HP, Berchtold W et al. (1985) Intravenous immunoglobulin versus oral corticosteroids in acute immune thrombocytopenic purpura in childhood. Lancet 2:464–468 Imbach P, Akatsuka J, Blanchette V et al. (1995) Immunthrombocytopenic purpura as a model for pathogenesis and treatment of autoimmunity. EurJ Pediatr 154:S60–S64 Imbach PA, Kühne T, Hollander G (1997) Immunologic aspects in the pathogenesis and treatment of immune thrombocytopenic purpura in children. Curr Opin Pediatr 9:35–40 Infectious Diseases and Immunization Committee, Canadian Paediatrice Society (1999) Prevention and therapy of bacterial infections for children with asplenia or hyposplenia. Pediatr Child Health 4:417–421 Iyori H, Bessho F, Ookawa H et al. (2000) Intracranial hemorrhage in children with immune thrombocytopenic purpura. Japanese Study Group on childhood ITP. Ann Hematol 79:691–695 Jayabose S, Levendoglu-Tugal Oya, Ozkayanak MF et al. (2003) Use of vincristine and cyclosporine in childhood thrombotic thrombocytopenic purpura. J Pediatr Hematol Oncol 25:421–428 Klaassen RJ, Doyle JJ, Krahn MD et al. (2001) Initial bone marrow aspiration in childhood idiopathic thrombocytopenia: decision analysis. J Pediatr Hematol Oncol 23:511–518 Kühne T (1999) Intercontinental childhood ITP registry. Med Pediatr Oncol 105:1130–1132 Kühne T, Elinder G, Blanchette VS et al. (1998) Current management issues of childhood and adult immune thrombocytopenic purpura (ITP). Acta Paediatr 424:75–81 Kühne T, Buchanan GR, Zimmerman S et al. (2003) A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the intercontinental childhood ITP study group. J Pediatr 143:605–608 Lilleyman JS (1999) Management of childhood idiopathic thrombocytopenic purpura. Br J Haematol 105:871–875 Lilleyman JS (2003) Medical nemesis and childhood ITP. Br J Hematol 123:586–589 Lusher JM, Zuelzer WW (1966) Idiopathic thrombocytopenic purpura in childhood. J Pediatr 68:971–979 Lusher JM, Emami A, Ravindranath Y et al. (1984) Idiopathic thrombocytopenic purpura in children. Am J Pediatr Hematol Oncol 6:149–157 Mantadakis E, Buchanan GR (2000) Elective splenectomy in children with idiopathic thrombocytopenic purpura. Postgrad Med J 76:299–300 Medeiros D, Buchanan GR (1996) Current controversies in the management of idiopathic thrombocytopenic purpura during childhood. Pediatr Clin North Am 43:757–772 Medeiros D, Buchanan GR (1998) Major hemorrhage in children with idiopathic thrombocytopenic purpura: immediate response to therapy and long-term outcome. J Pediatr 133:334–339 Meeker ND, Goldsby R, Terrill KR et al. (2003) Dapsone therapy for children with immune thrombocytopenic purpura. J Pediatr Hematol Oncol 25:173–175 Miller E, Waight P, Farrington P et al. (2001) Idiopathic thrombocytopenic purpura and MMR vaccine. Arch Dis Child 84:227–229 Moskowitz IP, Gaynon PS, Shahidi NT et al. (1999) Low-dose cyclosporin A therapy in children with refractory immune thrombocytopenic purpura. J Pediatr Hematol Oncol 21:77–79 Murdoch IA, Beattie RM, Silver DM (1993) Heparin-induced thrombocytopenia in children. Acta Paediatr 82:495–497 Najean Y, Rain JD, Billotey C (1997) The site of destruction of autologous 111In-labelled platelets and the efficiency of splenectomy in children and adults with idiopathic thrombocytopenic purpura: a study of 578 patients with 268 splenectomies. Br J Haematol 97:547–550 Ozer EA, Yaprak I, Atabay B et al. (2000) Oral cyclic megadose methylprednisolone therapy for chronic immune thrombocytopenic purpura in childhood. Eur J Haematol 64:411–415 Reid MM (1995) Chronic idiopathic thrombocytopenic purpura: incidence, treatment, and outcome. Arch Dis Child 72:125–128 Rosthoj S, Hedlund-Terutiger I, Rajantie J et al. (2003) Duration and morbidity of newly diagnosed idiopathic thrombocytopenic purpura in children: a prospective Nordic study of an unselected cohort. J Pediatr 143:302–307 Ruivard M, Caulier MT, Vantelon JM et al. (1999) The response to high-dose intravenous immunoglobulin or steroids is not predictive of outcome after splenectomy in adults with autoimmune thrombocytopenic purpura. Br J Haematol 105:1130–1132 Salzmann MB, Smith EM (1998) Phenytoin-induced thrombocytopenia treated with intravenous immune globulin. J Pediatr Hematol Oncol 20:152–153 Sandler S (2001) Treating immune thrombocytopenic purpura and preventing Rh alloimmunization using intravenous Rho (D) immune globulin. Transfus Med Rev 15:67–76 Sartorius JA (1984) Steroid treatment of idiopathic thrombocytopenic purpura in children. Am J Pediatr Hematol Oncol 6:165–169 Saxon BR, Blanchette VS, Butchart S et al. (1998) Reticulated platelet counts in the diagnosis of acute immune thrombocytopenic purpura. J Pediatr Hematol Oncol 20:44–48 Scaradavou A, Woo B, Woloski BM et al. (1997) Intravenous anti-D treatment of immune thrombocytopenic purpura: experience in 272 patients. Blood 89:2689–2700 Scheurlen W, Ramasubbu K, Wachowski O et al. (2001) Chronic autoimmune thrombopenia/neutropenia in a boy with persistent parvovirus B19 infection. J Clin Virol 20:173–178 Sutor AH (1998) Acute immune thrombocytopenia in childhood. Are we treating the platelet count? Semin Thromb Hemost 24:545–548 Sutor A, Harms A, Kaufmehl K (2001) Acute immune thrombocytopenia (ITP) in childhood: retrospective and prospective survey in Germany. Semin Thromb Hemost 27:253–267 Tamary H, Kaplinsky C, Levy I et al. (1994) Chronic childhood idiopathic thrombocytopenia purpura: long-term follow-up. Acta Paediatr 83:931–934 Tarantino MD (2000) Treatment options for chronic immune (idiopathic) thrombocytopenia purpura in children. Semin Hematol 37:31–34 Tarantino M, Madden R, Fennewald DL et al. (1999) Treatment of childhood acute immune thrombocytopenic purpura with anti-D immune globulin or pooled immune globulin. J Pediatr 134:21–25 Vesely SK, Buchanan G, Adix L et al. (2003) Self-reported initial management of childhood idiopathic thrombocytopenic purpura: results of a survey of members of the American Society of Pediatric Hematology/Oncology, 2001. J Pediatr Hematol Oncol 25:130–133 Warrier I, Bussel JB, Valdez L et al. (1997) Safety and efficacy of low-dose intravenous immune globulin (IVIG) treatment for infants and children with immune thrombocytopenic purpura. Low-Dose IVIG Study Group. J Pediatr Hematol Oncol 19:197–201 Williams JA, Boxer LA (2003) Combination therapy for refractory idiopathic thrombocytopenic purpura in adolescents. J Pediatr Hematol Oncol 25:232–235 Yetgin S, Olcay L, Ozsoylu S et al. (1997) Retrospective analysis of 78 children with chronic idiopathic thrombocytopenic purpura: follow-up from 1976 to 1996. Pediatr Hematol Oncol 14:399–412 Zeller B, Helgestad J, Hellebostad M et al. (2000) Immune thrombocytopenic purpura in childhood in Norway: a prospective, population-based registration. Pediatr Hematol Oncol 17:551–558 Zimmermann SA, Ware RE (1997) Clinical significance of the antinuclear antibody test in selected children with idiopathic thrombocytopenic purpura. J Pediatr Hematol Oncol 19:297–303 Zimmermann SA, Malinoski FJ, Ware RE (1998) Immunologic effects of anti-D (WinRho-SD) in children with immune thrombocytopenic purpura. Am J Hematol 57:131–138 Zunich KM, Harkonen WS, Woloski M et al. (1995) Intravenous anti-D immunoglobulin for childhood acute immune thrombocytopenic purpura. Lancet 346:1363–1365